Defective ATM-p53-mediated apoptotic pathway in multiple sclerosis

被引:29
作者
Deng, XQ [1 ]
Ljunggren-Rose, A [1 ]
Maas, K [1 ]
Sriram, S [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA
关键词
D O I
10.1002/ana.20600
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Defective elimination of autoreactive cells is thought to play a role in the development of autoimmune diseases including multiple sclerosis (MS). We examined the activation of the ATM-CHK2-p53 pathway in MS patients after subjecting their peripheral blood mononuclear cells to gamma-irradiation. We found that peripheral blood mononuclear cells from a subset of MS patients show resistance to cell death induced by irradiation. This defect is due to impaired constitutive expression and activation of ATM (ataxia telangiectasia mutated), resulting in impaired stabilization of p53. We predict that these fundamental defects likely alter the regulation of the immune population of cells in MS and may contribute to the development or progression of the disease.
引用
收藏
页码:577 / 584
页数:8
相关论文
共 47 条
[1]   Cell cycle checkpoint signaling through the ATM and ATR kinases [J].
Abraham, RT .
GENES & DEVELOPMENT, 2001, 15 (17) :2177-2196
[2]   Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress [J].
Amundson, SA ;
Myers, TG ;
Fornace, AJ .
ONCOGENE, 1998, 17 (25) :3287-3299
[3]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[4]   Gene expression profiles in human autoimmune disease [J].
Aune, TM ;
Maas, K ;
Moore, JH ;
Olsen, NJ .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (23) :1905-1917
[5]   Enhanced phosphorylation of p53 by ATN in response to DNA damage [J].
Banin, S ;
Moyal, L ;
Shieh, SY ;
Taya, Y ;
Anderson, CW ;
Chessa, L ;
Smorodinsky, NI ;
Prives, C ;
Reiss, Y ;
Shiloh, Y ;
Ziv, Y .
SCIENCE, 1998, 281 (5383) :1674-1677
[6]   Transcription-based prediction of response to IFNβ using supervised computational methods [J].
Baranzini, SE ;
Mousavi, P ;
Rio, J ;
Caillier, SJ ;
Stillman, A ;
Villoslada, P ;
Wyatt, MM ;
Comabella, M ;
Greller, LD ;
Somogyi, R ;
Montalban, X ;
Oksenberg, JR .
PLOS BIOLOGY, 2005, 3 (01) :166-176
[7]   The apoptotic and transcriptional transactivation activities of p53 can be dissociated [J].
Bissonnette, N ;
Wasylyk, A ;
Hunting, DJ .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1997, 75 (04) :351-358
[8]   Post-translational modification of p53 in tumorigenesis [J].
Bode, AM ;
Dong, ZG .
NATURE REVIEWS CANCER, 2004, 4 (10) :793-805
[9]   Gene expression profile in multiple sclerosis patients and healthy controls:: identifying pathways relevant to disease [J].
Bomprezzi, R ;
Ringnér, M ;
Kim, S ;
Bittner, ML ;
Khan, J ;
Chen, YD ;
Elkahloun, A ;
Yu, AM ;
Bielekova, B ;
Meltzer, PS ;
Martin, R ;
McFarland, HF ;
Trent, JM .
HUMAN MOLECULAR GENETICS, 2003, 12 (17) :2191-2199
[10]  
Burns TF, 1999, J CELL PHYSIOL, V181, P231, DOI 10.1002/(SICI)1097-4652(199911)181:2<231::AID-JCP5>3.0.CO